To protect your child, their doctor will give them the pneumococcal conjugate vaccine (PCV). "This is a great example of a vaccine that protects against invasive disease from a bacteria we see causing ...

The European Commission approves MRK's pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in adults.

Eligible study participants diagnosed during 2004 were excluded from the study as this specific year represented the transition period from pre- to post-PCV7 vaccine era. All MEF cultures obtained ...

Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...

Background Widespread use of 7-valent pneumococcal conjugate vaccine (PCV7) in children has led to significant reduction in pneumococcal disease in children and adults. However, diseases caused by ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

The successful introduction of PCV and Rotavirus vaccines in South Sudan is a huge victory for one nation and it is also a regional achievement. [iStockphoto] South Sudan is one of the countries ...